[
  {
    "question": "Which one is feature of dominant parietal?",
    "option_a": "finger agnosis",
    "option_b": "sensory nglect",
    "option_c": "Apraxia",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Dementia",
    "explanation": "Dominant parietal lobe syndrome, often resulting from lesions in the left parietal region (most commonly the angular gyrus), is classically associated with Gerstmann syndrome. This syndrome is characterized by a constellation of deficits including finger agnosia, left-right disorientation, agraphia, and acalculia. Lesions affecting the dominant (usually left) parietal lobe interfere with the integration of sensory, spatial, and language-related information. The disruption in cortical processing leads to difficulties in recognizing one\u2019s own fingers (finger agnosia) and other associated symptoms of Gerstmann syndrome. Patients with dominant parietal lobe lesions may present with difficulties in tasks involving finger recognition (finger agnosia), with additional deficits in writing, calculation, and orientation, but they typically do not exhibit sensory neglect. Sensory neglect is more commonly associated with non-dominant (usually right) parietal lobe lesions. Differential diagnoses include non-dominant parietal lobe syndrome (characterized by spatial neglect), apraxia resulting from premotor cortex lesions, and broader parietal lobe dysfunction seen in conditions such as stroke. Detailed neuropsychological testing and imaging (MRI) help delineate the exact location and extent of the dysfunction. The management of parietal lobe lesions depends on the underlying etiology. For stroke-induced lesions, acute management follows stroke protocols with secondary prevention strategies; for tumors, surgical resection may be indicated. In settings like degenerative disease, supportive therapies and rehabilitation (occupational and speech therapy) are essential. Pregnancy or lactation considerations are rarely applicable in these cases but require multidisciplinary consultation if encountered. Option A (finger agnosia) is correct because it is a classic component of Gerstmann syndrome seen in dominant parietal lobe lesions. Option B (sensory neglect) is typically associated with lesions in the non-dominant parietal lobe. Option C (apraxia) can be seen with left hemisphere lesions but is less specific than the classic symptom of finger agnosia for dominant parietal involvement; moreover, it is not one of the hallmarks of Gerstmann syndrome. 1. Gerstmann syndrome is highly suggestive of a lesion in the dominant parietal lobe. 2. Sensory neglect is seen with non-dominant parietal injury. 3. A comprehensive neuropsychological evaluation is crucial for accurate localization. Contemporary studies underline the importance of correlating neuropsychological findings with imaging to accurately localize parietal lobe dysfunction. Recent neuroimaging advancements enhance our ability to map these deficits, thereby guiding targeted therapies and rehabilitation.",
    "exam_year": "2023",
    "exam_type": "Promotion"
  },
  {
    "question": "Donpezil mechanism of action?",
    "option_a": "ace inhibitor",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "Acetylcholinesterase inhibitor",
    "subspecialty": "Dementia",
    "explanation": "Donepezil is a medication used primarily for the symptomatic treatment of Alzheimer\u2019s disease. It works by enhancing cholinergic function in the brain, which is deficient in Alzheimer\u2019s disease. In Alzheimer\u2019s disease, there is a reduction in the activity of cholinergic neurons leading to decreased levels of acetylcholine, a neurotransmitter vital for memory and cognition. Donepezil inhibits the enzyme acetylcholinesterase, which normally degrades acetylcholine. This inhibition increases the concentration of acetylcholine in the synaptic cleft, thereby partially compensating for the cholinergic deficit. The increased synaptic availability of acetylcholine can lead to improvements in cognitive symptoms such as memory, attention, and executive functions in patients with mild to moderate Alzheimer\u2019s disease. However, it is only symptomatic treatment and does not halt disease progression. The use of Donepezil is considered after a clinical diagnosis of Alzheimer\u2019s disease is established, based on clinical assessment, neuropsychological testing, and supportive imaging. Differential diagnoses include other causes of dementia such as vascular dementia, Lewy body dementia, and frontotemporal dementia, all of which require tailored therapeutic approaches. According to current guidelines, donepezil is recommended as first-line pharmacotherapy for mild to moderate Alzheimer\u2019s disease. It is typically started at a low dose and titrated upward based on efficacy and tolerability. In pregnant or lactating women, donepezil is generally contraindicated unless the potential benefits outweigh the risks; its use in these populations should be reserved for cases with compelling indications and after thorough counseling. Option A (ACE inhibitor) is incorrect because ACE inhibitors are used mainly for hypertension and heart failure, not for cognitive decline. The correct mechanism of action for Donepezil is as an acetylcholinesterase inhibitor, which is not reflected in any of the provided options. Hence, the correct answer should state that Donepezil is an acetylcholinesterase inhibitor. 1. Donepezil is a mainstay of symptomatic treatment in Alzheimer\u2019s disease. 2. It does not modify the disease course but may improve or stabilize cognitive symptoms temporarily. 3. Beware of gastrointestinal side effects and bradycardia, particularly in elderly patients. Recent updates continue to support the use of acetylcholinesterase inhibitors as first-line treatments for Alzheimer\u2019s disease, despite modest efficacy. Ongoing research aims to better understand their long-term impact and potential combination with other disease-modifying therapies.",
    "exam_year": "2023",
    "exam_type": "Promotion"
  },
  {
    "question": "elderly male was brought by his family with urinary incontinence for y and cognitive declinr mmse 25/30 has bradykinasia and mild rigidity no tremors and had suffling gait with magnatic gait mri ventriculomegaly and mild volume loss what\u2019s your management",
    "option_a": "Trial of dopa",
    "option_b": "DBS",
    "option_c": "Refer for elective shunt",
    "option_d": "",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Dementia",
    "explanation": "The clinical vignette describes a classic presentation of Normal Pressure Hydrocephalus (NPH), which is characterized by the triad of gait disturbance (magnetic gait), urinary incontinence, and cognitive decline. The enlarged ventricles on MRI with relatively preserved cortical volume support this diagnosis. NPH results from a disturbance in cerebrospinal fluid (CSF) absorption that leads to ventricular dilation without a corresponding increase in intracranial pressure. The expansion of the ventricular system exerts pressure on the surrounding brain tissue, particularly frontal lobe and periventricular white matter, leading to the typical clinical triad noted in NPH. The patient\u2019s presentation with urinary incontinence, mild cognitive impairment (MMSE 25/30), bradykinesia, rigidity, and a shuffling, magnetic gait aligns with the diagnosis of NPH. The absence of tremors helps to differentiate it from primary Parkinson\u2019s disease, and the imaging findings further support this diagnosis. Differential diagnoses include Parkinson\u2019s disease (which typically presents with tremors and a different pattern of rigidity), vascular dementia (which would show more focal infarcts or white matter changes), and Alzheimer\u2019s disease (which generally presents with memory loss as a prominent feature). A high-volume lumbar puncture (tap test) is often used to predict responsiveness to shunt surgery before the procedure is performed. The first step in management is usually a CSF tap test to assess improvement in symptoms. If there is improvement, the next step is the placement of a ventriculoperitoneal (VP) shunt (elective shunting). This is considered first-line treatment for NPH in appropriately selected patients. DBS and trial of dopamine (dopa) are not indicated in NPH. Although most patients are elderly, if a younger individual were diagnosed while pregnant or lactating (rare scenario), surgical intervention would involve multidisciplinary evaluation, but typically NPH is not seen in pregnancy. Option A (Trial of dopa) is more suitable for Parkinson\u2019s disease, which is less likely given the absent tremors and MRI findings. Option B (DBS) is used in the management of advanced Parkinson's disease and is not applicable here. Option C (Refer for elective shunt) is correct because the clinical presentation, imaging, and classic triad strongly indicate NPH as the underlying cause, with shunt surgery being the established treatment in responsive cases. 1. The classic triad of NPH includes gait disturbance, urinary incontinence, and cognitive decline. 2. Improvement after a lumbar tap test is a key predictor of shunt responsiveness. 3. Early intervention with shunt placement can significantly improve quality of life. Recent guidelines and studies underscore the benefits of early recognition and surgical intervention for NPH. Advances in programmable shunt technology have improved outcomes and reduced complications. Close postoperative monitoring is necessary for optimum long-term results.",
    "exam_year": "2023",
    "exam_type": "Promotion"
  },
  {
    "question": "Elderly patient presented with visual field defect but she denied, she had left homogenous hemianopia. CT brain done. What is the explanation of her issue:",
    "option_a": "(Visual anosognosia) is correct because it specifically explains the dissociation between the patient\u2019s visual field loss and her awareness of it, which is due to cortical damage affecting self",
    "option_b": "(Psychiatric) is incorrect as it wrongly attributes the deficit to a psychiatric origin rather than a neurological one; the denial is unintentional and tied to brain injury rather than a psychological defense mechanism. Option c (Apraxia) is unrelated because apraxia involves difficulty with motor planning and execution, not the denial of sensory deficits such as visual fields.",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "a",
    "subspecialty": "Dementia",
    "explanation": "Visual anosognosia is a phenomenon in which a patient is unaware of, or denies, their visual deficit despite clear objective evidence indicating a visual field loss. This lack of awareness is not due to a psychiatric condition but rather is a direct consequence of neurological injury, often associated with right hemisphere or occipital lobe damage. The mechanism underlying visual anosognosia involves damage to the primary and associative visual cortices, as well as disruption of the neural networks responsible for self-awareness and visual processing. In cases such as right occipital or parietal lobe infarction, the disconnect between the damaged visual processing areas and the perception of function leads to a denial of deficit. Anton syndrome is an extreme form of this phenomenon, where patients are cortically blind yet deny their blindness due to the impairment of self-monitoring circuits. In the described elderly patient, the presence of a left homogenous hemianopia indicates a likely lesion in the right occipital lobe. The patient\u2019s denial of the visual loss is characteristic of visual anosognosia, linking the clinical presentation with damage to neural circuits responsible for self-awareness. This phenomenon helps differentiate neurological deficits from psychiatric conditions, in which denial is typically more psychologically mediated. Diagnosis relies on neuroimaging such as CT or MRI to localize the lesion (typically in the right occipital or posterior parietal region), alongside a detailed neuro-ophthalmologic assessment. Differential diagnoses include: (1) occipital lobe stroke or infarct, (2) neurodegenerative disorders affecting visual processing, and (3) psychiatric conditions where denial is not based on cortical dysfunction but on psychological defense mechanisms. The clear imaging evidence and neuropsychological testing assist in clarifying the diagnosis. Management focuses on the underlying cause, often an ischemic stroke or other vascular event. First-line management entails supportive neurorehabilitation, including visual and cognitive therapy to help the patient compensate for the deficit. Second-line measures may include occupational therapy and, where appropriate, pharmacotherapy for secondary prevention of stroke. For pregnant or lactating patients, imaging choices should favor modalities with lower or no ionizing radiation (e.g., MRI over CT when possible) and medications must be selected with safety profiles in mind according to the latest obstetric guidelines. Early identification and tailored stroke management can improve outcome and functional recovery. Option a (Visual anosognosia) is correct because it specifically explains the dissociation between the patient\u2019s visual field loss and her awareness of it, which is due to cortical damage affecting self-awareness. Option b (Psychiatric) is incorrect as it wrongly attributes the deficit to a psychiatric origin rather than a neurological one; the denial is unintentional and tied to brain injury rather than a psychological defense mechanism. Option c (Apraxia) is unrelated because apraxia involves difficulty with motor planning and execution, not the denial of sensory deficits such as visual fields. 1. Right hemisphere damage, especially in the occipital and parietal regions, is frequently associated with neglect of the left visual field and unawareness of visual deficits. 2. Anton syndrome, a form of visual anosognosia, highlights the intriguing dissociation between sensory loss and self-awareness following cortical injury. 3. Neuroimaging and thorough neuropsychological evaluation are crucial in differentiating neurological anosognosia from psychiatric denial. Recent research emphasizes the role of disrupted fronto-parietal and visual association networks in the development of anosognosia. Updated stroke guidelines advocate for early and comprehensive rehabilitation to address not just motor deficits but also cognitive and sensory awareness issues. In addition, guidelines for imaging and treatment in pregnant or lactating patients stress minimizing radiation exposure and choosing safe therapeutic agents, ensuring that management adheres to the best practices in both neurology and obstetrics.",
    "exam_year": "2023",
    "exam_type": "Promotion"
  },
  {
    "question": "Patient known case of congenital heart disease presented with headache, fever and hemiparesis what will you do next:",
    "option_a": "Blood culture",
    "option_b": "CT without contrast",
    "option_c": "CT with contrast",
    "option_d": "LP",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Neuro-infectious",
    "explanation": "This case highlights the classic presentation of a brain abscess \u2013 headache, fever, and focal neurological deficits \u2013 in a patient with congenital heart disease. In such patients, right\u2010to\u2010left shunts foster the hematogenous spread of infection leading to brain abscess formation. In patients with congenital heart disease, especially those with right-to-left shunts, bacteria bypass the pulmonary filter allowing septic emboli to reach the cerebral circulation. This can lead to a localized infection with the formation of an abscess, typically characterized by a central area of necrosis with a surrounding capsule. CT with contrast best delineates a ring-enhancing lesion typical of brain abscesses. The triad of headache, fever, and hemiparesis in a congenital heart disease patient is highly suggestive of a brain abscess. Neurological deficits result from mass effect or local inflammation, while fever indicates an active infectious process. The initial diagnostic step is neuroimaging. CT with contrast is the modality of choice to identify ring-enhancing lesions. Differential diagnoses include ischemic stroke, neoplasm, or subdural empyema. A lumbar puncture (LP) is contraindicated in the presence of a mass effect due to the risk of herniation, and blood cultures, while useful later, are not immediately diagnostic of the intracranial lesion. First-line management includes prompt neuroimaging, broad-spectrum intravenous antibiotics tailored against common causative organisms, and neurosurgical consultation for possible drainage. In pregnancy or lactation, the risk\u2013benefit ratio of imaging must be weighed, but emergent imaging is generally indicated with appropriate shielding. Once the abscess is confirmed, antibiotic regimens may include agents like vancomycin, Ceftriaxone, and metronidazole, and adjustments are made based on culture results. Option A (Blood culture) is important but not the immediate next step given the risk of herniation; Option B (CT without contrast) might miss the typical ring enhancement; Option C (CT with contrast) is correct as it accurately identifies the lesion; Option D (LP) is contraindicated in suspected mass lesions due to the risk of brain herniation. 1. Congenital heart disease predisposes to brain abscess due to right-to-left shunting. 2. Always use contrast in CT imaging for suspected brain abscesses. 3. Avoid LP if there is suspicion of a mass lesion to prevent herniation. Contemporary guidelines emphasize the importance of rapid neuroimaging (preferably CT with contrast) in the evaluation of suspected brain abscesses. Recent studies underline the role of early surgical intervention alongside antibiotic therapy to reduce morbidity and mortality.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "Case of bacterial meningitis, what\u2019s the most common organism:",
    "option_a": "Pneumococcus",
    "option_b": "N.gonorrhoeae",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "Bacterial meningitis is a life-threatening infection of the meninges. Streptococcus pneumoniae (pneumococcus) is universally recognized as the most common pathogen causing community-acquired bacterial meningitis in adults. S. pneumoniae invades the bloodstream and penetrates the meninges, triggering a robust inflammatory response. The bacterial cell wall components release toxins that lead to cerebral edema, increased intracranial pressure, and neuronal injury. Patients typically present with headache, fever, neck stiffness, and altered mental status. The rapid progression and severity of symptoms necessitate prompt recognition and intervention. The standard diagnostic approach includes lumbar puncture (after ruling out contraindications) with CSF analysis (cell count, protein, glucose, Gram stain and culture). Differential diagnoses include viral meningitis (which has a more benign course), tuberculous meningitis (which has a more insidious onset), and fungal meningitis (often seen in immunocompromised hosts). Immediate empiric antibiotic therapy is crucial. First-line regimens typically include vancomycin and a third-generation cephalosporin (such as ceftriaxone). In patients over 50 or with immunocompromise, ampicillin is added to cover Listeria monocytogenes. Pregnancy and lactation require careful antibiotic selection, but agents like ampicillin and ceftriaxone are generally considered safe. Option A (Pneumococcus) is correct given its epidemiological predominance in adult bacterial meningitis. Option B (N. gonorrhoeae) is not a common cause of meningitis in this population and is more associated with other types of infections. 1. S. pneumoniae is the leading cause of bacterial meningitis in adults. 2. Early administration of antibiotics improves outcomes. 3. Always consider patient age and risk factors when selecting empiric therapy. Recent guidelines continue to support the rapid initiation of empiric therapy with a high-dose cephalosporin and vancomycin, with the addition of ampicillin for Listeria coverage in appropriate age groups. Adjunctive dexamethasone is also recommended in some protocols to reduce neurological complications.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "Scenario of diabetic patient with history of sinusitis and focal neurological deficit, what is the diagnosis?",
    "option_a": "Mucormycosis",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "In diabetic patients, particularly those with a history of sinusitis, the development of a focal neurological deficit raises high suspicion for invasive fungal infections, notably mucormycosis. This infection is aggressively angioinvasive, often affecting the sinuses and adjacent brain structures. Mucormycosis is caused by fungi belonging to the order Mucorales. In diabetics, especially those in ketoacidosis, high serum glucose and acidic pH impair the host's immune response and promote fungal proliferation. The fungi invade blood vessel walls, causing thrombosis, tissue necrosis, and infarction. Patients may present with signs of sinusitis that progress to orbital or cerebral involvement, manifesting as facial pain, swelling, cranial nerve deficits, or focal neurological impairments. Early diagnosis is critical due to the rapid progression and high mortality rate. Diagnosis typically involves imaging studies such as CT or MRI of the sinuses and brain to assess the extent of invasion. Definitive diagnosis is confirmed by biopsy and histopathological examination, which shows broad, non-septate hyphae with right-angle branching. Differential diagnoses include bacterial sinusitis, bacterial brain abscess, and other fungal infections such as aspergillosis. The cornerstone of management is early and aggressive treatment with high-dose intravenous amphotericin B and urgent surgical debridement of necrotic tissue. For pregnant or lactating patients, amphotericin B is considered category B and is the treatment of choice due to its favorable safety profile in these populations. Glycemic control is also essential in diabetic patients to reduce the risk of progression. Option A (Mucormycosis) is correct based on the patient\u2019s risk factors (diabetes and sinusitis) and the clinical presentation (focal neurological deficit). The other options are incomplete or irrelevant to the typical pathogens in this scenario. 1. Diabetics, especially those with ketoacidosis, are at high risk for mucormycosis. 2. Early recognition and prompt surgical and antifungal therapy are crucial to outcome. 3. Rhinocerebral spread can lead to rapid neurological deterioration. Recent research emphasizes the aggressive nature of mucormycosis and supports the use of early combined surgical and antifungal therapy. Updated guidelines continue to recommend amphotericin B as first-line therapy, with posaconazole or isavuconazole as alternative or salvage therapies.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "Diabetic male older than 50-year-old, what kind of organisms do you expect to see if he developed meningitis:",
    "option_a": "Streptococcus pneumoniae, Listeria monocytogenes",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "Meningitis in older adults, particularly in those with diabetes, requires comprehensive coverage due to age-related and comorbidity-related susceptibilities. The typical organisms in this population include Streptococcus pneumoniae and Listeria monocytogenes. With advancing age and diabetes, immunosenescence and impaired phagocytic function increase susceptibility to certain bacteria. Listeria monocytogenes is known for its intracellular survival and ability to invade the central nervous system, while Streptococcus pneumoniae remains a leading cause of community-acquired meningitis. Patients over 50 or those with underlying conditions such as diabetes present with meningitis symptoms like fever, headache, and altered mental status. Empiric coverage must address both typical pathogens including S. pneumoniae and Listeria. The diagnostic workup involves lumbar puncture for CSF analysis, which includes Gram stain, culture, and biochemical analysis. Differential diagnoses include viral meningitis, tuberculous meningitis, and encephalitis. The patient's age and risk factors direct the need for broader coverage. Empiric treatment for bacterial meningitis in patients over 50 or with diabetes should include a third-generation cephalosporin and vancomycin, with the addition of ampicillin to cover Listeria. In pregnancy and lactation, antibiotic choices are adjusted to ensure fetal safety; ampicillin remains a safe option, while vancomycin and cephalosporins are also generally regarded as safe. Option A, which lists both Streptococcus pneumoniae and Listeria monocytogenes, is correct as it covers the most likely organisms in an older diabetic patient with meningitis. The other options are either incomplete or do not account for the full spectrum of potential pathogens in this demographic. 1. Always include Listeria coverage in patients over 50 or those with diabetes when treating meningitis. 2. Empiric antibiotic regimens must be broadened in older or immunocompromised patients. 3. Rapid diagnosis and treatment initiation are critical to reducing morbidity and mortality. Recent guidelines from infectious disease societies support the inclusion of ampicillin for Listeria coverage in older patients with meningitis. Studies continue to emphasize early broad-spectrum antibiotic coverage, with subsequent tailoring based on identified pathogens and sensitivity profiles.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "HIV, CD4 count 60, single ring enhancing lesion at white grey matter junction, minimal edema, next step:",
    "option_a": "is not provided; Option B (LP) is not useful because CSF findings in toxoplasmosis are non",
    "option_b": "LP",
    "option_c": "Brain biopsy",
    "option_d": "Chest x ray",
    "option_e": "start sulfadiazine plus pyrimethamine",
    "correct_answer": "E",
    "subspecialty": "Neuro-infectious",
    "explanation": "In HIV/AIDS patients with a very low CD4 count (especially <100 cells/mm\u00b3), the appearance of ring\u2010enhancing lesions on neuroimaging is most commonly due to reactivation of latent Toxoplasma gondii infection. Such patients often present with neurological deficits, headache, and sometimes fever, making cerebral toxoplasmosis the most likely diagnosis in this setting. Toxoplasma gondii, an obligate intracellular parasite, remains latent in the tissues and reactivates in immunocompromised individuals. In the brain, reactivation leads to focal areas of necrotizing encephalitis that manifest as ring\u2010enhancing lesions at the gray-white matter junction. The minimal edema seen in some lesions may be due to the host's impaired inflammatory response. Patients present with headaches, confusion, focal neurological deficits (such as motor weakness or seizures), and sometimes fever. The location of the lesions at the corticomedullary junction and their ring-enhancing characteristics on CT or MRI are typical findings in cerebral toxoplasmosis in HIV-positive individuals. The differential includes primary CNS lymphoma, which can also produce ring-enhancing lesions. An empiric trial of anti-toxoplasmosis therapy is typically initiated; if there is no clinical or radiographic improvement within 10-14 days, further diagnostic evaluation via brain biopsy may be warranted. Cerebrospinal fluid analysis is usually non-specific in toxoplasmosis, and other tests (e.g., PCR) are not routinely diagnostic. Current guidelines recommend initiating first-line therapy with a combination of sulfadiazine plus pyrimethamine along with folinic acid (leucovorin) to counteract bone marrow suppression. This treatment is considered the empiric standard. In cases where there is no improvement after 10-14 days, brain biopsy may be considered. In pregnant patients, treatment needs modification\u2014early in pregnancy spiramycin may be used for prophylaxis against congenital transmission, though CNS involvement in the mother necessitates a careful balance between maternal benefit and fetal risk. During lactation, most of these agents are only minimally secreted into breast milk, but risk-benefit discussions are essential. Option A is not provided; Option B (LP) is not useful because CSF findings in toxoplasmosis are non-specific and may delay appropriate therapy; Option C (Brain biopsy) is reserved for patients not responding to empiric therapy; Option D (Chest x\u2011ray) is aimed at evaluating for tuberculosis or fungal infections but is not indicated in this classic setting; Option E (start sulfadiazine plus pyrimethamine) is the correct next step as it directly addresses the most likely diagnosis \u2013 cerebral toxoplasmosis. 1. In HIV patients with CD4 counts <100, a ring-enhancing lesion is most often due to toxoplasmosis, warranting an empiric trial of therapy. 2. The lack of improvement after 10-14 days of appropriate therapy should prompt further investigation, including consideration of brain biopsy. 3. Prophylaxis with TMP-SMX can reduce the incidence of toxoplasmosis in patients with advanced HIV. Recent studies and updated HIV management guidelines continue to support empiric treatment of suspected cerebral toxoplasmosis with sulfadiazine and pyrimethamine, reserving invasive diagnostics for refractory cases. Early intervention has been consistently shown to reduce morbidity and mortality in these patients.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "Patient came with one-month history of increased thirst, headache fever and personality changes Brain MRI showed bilateral cortical and subcortical hypodensities on T2 involving frontal, parietal, and occipital lobe, hypothalamus, midbrain, pones and medulla, LP done CSF showed less than 20 WBS 99% lymphocyte, low glucose and high protein, mentioned negative culture:",
    "option_a": "Neurosarcoidosis",
    "option_b": "NeuroTB",
    "option_c": "NeuroBrucella",
    "option_d": "Lyme disease",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Neuro-infectious",
    "explanation": "Neurotuberculosis (NeuroTB) is a manifestation of extrapulmonary tuberculosis that often involves the meninges and brain parenchyma. It typically presents with subacute to chronic neurological symptoms, and its diagnosis is supported by a characteristic CSF profile and neuroimaging findings. Mycobacterium tuberculosis reaches the central nervous system via hematogenous spread, leading to the formation of a granulomatous inflammatory response. This results in the typical CSF findings of lymphocytic pleocytosis, elevated protein, and reduced glucose, owing to the consumption of glucose by the bacteria and the inflammatory cells. The patient\u2019s one-month history of symptoms including headache, fever, personality changes, and signs of hypothalamic involvement (which may explain increased thirst) are consistent with a subacute CNS process. The CSF analysis showing less than 20 white blood cells with a predominance of lymphocytes, low glucose, and high protein, despite a negative culture, is highly suggestive of tuberculous meningitis or a tuberculoma. Differential diagnoses include neurosarcoidosis, neurobrucellosis, and Lyme encephalitis. Neurosarcoidosis, while it can mimic TB, usually does not present with such a marked hypoglycorrhachia. Neurobrucellosis requires a specific exposure history (e.g., contact with livestock) and Lyme disease has a different CSF profile with usually normal glucose. Neuroimaging, particularly MRI, aids in distinguishing these entities by revealing patterns such as basal meningeal enhancement in TB. The standard of care involves initiating a multi-drug antituberculous regimen \u2013 typically isoniazid, rifampin, pyrazinamide, and ethambutol \u2013 for an extended duration (usually 9-12 months). Adjunctive corticosteroids are recommended to reduce inflammatory complications. In pregnant patients, the same antituberculous medications are used with careful monitoring; isoniazid is supplemented with pyridoxine to prevent neuropathy, rifampin is acceptable but requires monitoring, and pyrazinamide is generally considered when the benefits outweigh potential risks. Lactating mothers can generally use these medications as the excretion in breast milk is limited and monitored. Option A (Neurosarcoidosis) is less likely given the very low CSF glucose and the subacute presentation. Option B (NeuroTB) fits the clinical picture well with the matching CSF profile and imaging findings. Option C (NeuroBrucella) is rare and usually associated with a distinct exposure history. Option D (Lyme disease) typically shows normal or only slightly low glucose levels and presents with other stigmata such as erythema migrans. 1. Tuberculous meningitis typically presents with a lymphocytic CSF profile, low glucose, and high protein, and early treatment is critical. 2. Adjunctive corticosteroids have been shown to improve outcomes in TB meningitis. 3. A high index of suspicion is necessary in endemic areas or in patients with risk factors, even if cultures are initially negative. Recent updates from the World Health Organization and CDC continue to advocate for early initiation of antituberculous therapy plus corticosteroids in cases of suspected neuroTB, emphasizing the high morbidity and mortality associated with delays in treatment.",
    "exam_year": "2018",
    "exam_type": "Part I",
    "image_url": "page_19.png"
  },
  {
    "question": "Most common sporadic fatal viral meningoencephalitis worldwide:",
    "option_a": "EBV",
    "option_b": "HSV1",
    "option_c": "HHV6",
    "option_d": "CMV",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "Herpes Simplex Virus type 1 (HSV-1) encephalitis is recognized as the most common sporadic fatal viral encephalitis worldwide. It typically involves the temporal lobes and is distinguished by its rapid onset and severe clinical course. HSV-1 invades the central nervous system through retrograde spread via the olfactory or trigeminal nerves. Once in the brain, the virus replicates, producing a necrotizing encephalitis that primarily affects the temporal and sometimes the frontal lobes, leading to cerebral edema and hemorrhagic necrosis. Clinically, HSV encephalitis presents with acute onset of fever, altered mental status, seizures, and focal neurological deficits, particularly involving the temporal lobes (e.g., aphasia, behavioral changes). Rapid diagnosis and treatment are critical due to the high fatality rate if left untreated. Neuroimaging (especially MRI) typically shows hyperintense lesions in the temporal lobes on T2/FLAIR sequences. CSF analysis reveals a lymphocytic pleocytosis and may be hemorrhagic. Polymerase chain reaction (PCR) testing of the CSF for HSV DNA is the diagnostic standard. The cornerstone of management is to initiate high-dose intravenous acyclovir as soon as HSV encephalitis is suspected. Multiple clinical guidelines strongly recommend prompt antiviral therapy to reduce morbidity and mortality. In pregnancy and lactation, acyclovir is widely considered safe and remains the treatment of choice due to its benefits outweighing potential risks. Option A (EBV) is not typically associated with fatal encephalitis; Option B (HSV-1) is correct due to its established role as the most common cause of sporadic fatal viral encephalitis; Option C (HHV-6) is an infrequent cause and usually seen in immunocompromised hosts; Option D (CMV) is also predominantly an issue in immunocompromised individuals and does not usually present in a sporadic fashion in immunocompetent patients. 1. Immediate initiation of IV acyclovir significantly reduces mortality in HSV encephalitis. 2. MRI findings of temporal lobe involvement are near pathognomonic for HSV encephalitis. 3. CSF PCR for HSV has greatly improved diagnostic accuracy and should be obtained without delay. Recent research continues to underscore the paramount importance of early acyclovir therapy. PCR remains the gold standard for diagnosis, with clinical guidelines reinforcing early treatment even before confirmatory results are available.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "Patient known case of congenital heart disease presented with headache, fever and hemiparesis what will you do next:",
    "option_a": "Antibiotics",
    "option_b": "Antibiotics and aspiration of the lesion",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Neuro-infectious",
    "explanation": "Patients with congenital heart disease, particularly those with right-to-left shunts, are at increased risk for brain abscesses. This is due to bypassing the pulmonary filtration system, which normally helps clear septic emboli, allowing bacteria to seed the brain. In patients with congenital heart disease, particularly cyanotic conditions, septic emboli can travel directly to the cerebral circulation and seed an area of the brain, leading to abscess formation. The resulting localized infection leads to capsule formation, surrounding edema, and eventually mass effect, which may manifest as focal neurological deficits such as hemiparesis. A clinical presentation involving headache, fever, and focal neurological deficits (e.g., hemiparesis) in a patient with congenital heart disease should raise suspicion for a brain abscess. The focal deficit suggests a significant lesion with mass effect, which is common in this context. Diagnosis is typically confirmed via neuroimaging \u2013 contrast-enhanced CT or MRI will usually reveal a ring-enhancing lesion consistent with an abscess. Differential diagnoses include metastatic lesions, cerebral infarcts, or primary brain tumors. Echocardiography may also be used to evaluate for cardiac sources of emboli. The current standard of care in cases where there is evidence of a brain abscess with focal deficits is a combination of broad-spectrum intravenous antibiotics and neurosurgical intervention (aspiration or drainage). The choice between aspiration and complete excision may depend on the size, location, and number of abscesses. In pregnant patients, many first-line antibiotics such as third-generation cephalosporins and metronidazole are considered relatively safe, though a multidisciplinary approach is required to balance maternal and fetal risks. In lactating women, similar antibiotic regimens are generally acceptable, but monitoring and consultation with pediatrics may be warranted. Option A (Antibiotics alone) may be appropriate for very small abscesses or in situations where the lesion is not accessible. However, in the presence of focal deficits like hemiparesis, indicating significant mass effect, Option B (Antibiotics and aspiration of the lesion) is preferred as it provides both a diagnostic sample and therapeutic decompression. The marked answer (B) is thus appropriate. 1. Congenital heart disease with right-to-left shunts predisposes patients to brain abscesses due to the bypassing of the pulmonary filter. 2. Combined medical and surgical management improves outcomes in patients with brain abscesses presenting with focal deficits. 3. Early neurosurgical consultation is critical in the management of brain abscesses. Recent neurosurgical and infectious disease guidelines support the use of early surgical drainage combined with broad-spectrum antibiotics for brain abscess management, particularly when there are significant neurological deficits. Updated protocols also stress the importance of tailoring antibiotic therapy based on culture results obtained from aspirated material, and these recommendations extend to special populations such as pregnant and lactating women.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "When to add metronidazole to meningitis treatment:",
    "option_a": "Age >50",
    "option_b": "History of sinusitis, mastoiditis, otitis media",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Neuro-infectious",
    "explanation": "Bacterial meningitis is treated with broad-spectrum antibiotics to cover the most common pathogens. However, when there is a history of contiguous infections (such as sinusitis, mastoiditis, or otitis media), anaerobic bacteria may be involved. Metronidazole is added in these scenarios to specifically cover anaerobic pathogens that standard meningitis regimens might not adequately cover. Infections like sinusitis, mastoiditis, and otitis media can extend directly into the meninges. The associated spread can introduce anaerobic organisms into the subarachnoid space, leading to meningitis. Unlike the typical pathogens (e.g., Streptococcus pneumoniae or Neisseria meningitidis), anaerobes thrive in low-oxygen environments created by these localized infections, necessitating specific antimicrobial coverage. Patients with a history of these contiguous infections often present with symptoms of meningitis along with signs of the underlying ENT infection. Recognizing this clinical history is crucial because it directs clinicians to adjust their treatment regimen by including metronidazole to avoid therapeutic failure against anaerobic bacteria. Diagnosis of bacterial meningitis involves CSF analysis (cell count, protein, glucose, Gram stain, and cultures) and often imaging studies such as CT or MRI of the brain to rule out complications. A detailed patient history is important to assess for recent sinus, mastoid, or middle ear infections. Differential diagnoses include viral meningitis, fungal meningitis, and tuberculous meningitis, each differentiated by CSF profiles and clinical settings. For bacterial meningitis, initial management typically involves empiric antibiotics (a combination covering common pathogens such as vancomycin plus a third-generation cephalosporin). When a patient has a history of sinusitis, mastoiditis, or otitis media, anaerobic coverage with metronidazole is warranted as an adjunct. In pregnant or lactating women, the risks and benefits must be carefully weighed; current guidelines suggest that while metronidazole is generally avoided in the first trimester, its use may be justified later in pregnancy if the clinical scenario demands it, and it is considered relatively safe during lactation. Option B is correct because the presence of a history of sinusitis, mastoiditis, or otitis media increases the risk for anaerobic infections in meningitis. Option A (Age >50) does not specifically imply anaerobic coverage. Options C and D are missing, so they are not applicable. 1. Always inquire about antecedent ENT infections in a patient with meningitis to assess the need for anaerobic coverage. 2. Metronidazole is the drug of choice to cover anaerobes in cases of suspected contiguous spread. Recent guidelines from the Infectious Diseases Society of America (IDSA) continue to support the addition of metronidazole when clinical history suggests anaerobic involvement, emphasizing tailored antibiotic regimens based on both culture results and clinical context.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "40-year-old man is seen in the emergency for evaluation of retinal hemorrhage, hepatosplenomegaly, headache, fever every 3 days and right arm weakness. On examination, his temperature is 38.1C. He has some weakness of the right arm otherwise his examination is non-focal. He recently arrived from Africa. Which of the following is a highly diagnostic test?",
    "option_a": "",
    "option_b": "Blood smear",
    "option_c": "CSF PCR",
    "option_d": "Brain MRI",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Neuro-infectious",
    "explanation": "Malaria is a parasitic disease transmitted by the Anopheles mosquito. The definitive diagnosis relies on direct visualization of the parasite in red blood cells via a blood smear, which makes it a highly diagnostic and readily available test. Once the Plasmodium parasite enters the bloodstream, it invades red blood cells, leading to cyclical hemolysis, which results in periodic fever spikes. The accumulation of parasitized red cells in microvasculature can also lead to complications such as retinal hemorrhages and hepatosplenomegaly. The patient presents with periodic fever (every 3 days), retinal hemorrhage, hepatosplenomegaly, headache, and focal neurologic deficits, all in the context of recent travel from Africa \u2013 a region endemic for malaria. These findings are highly consistent with a malaria infection, and the blood smear is used to identify and quantify parasitemia. The primary diagnostic test for malaria is a peripheral blood smear with Giemsa staining, which allows for visualization and identification of the Plasmodium species. Differential diagnoses include viral hemorrhagic fevers, bacterial sepsis, and other causes of febrile illness with multi-organ involvement. However, the travel history, periodic rigor, and characteristic findings on the blood smear help differentiate malaria from these conditions. Management is based on the identified species and the severity of the disease. For uncomplicated malaria, oral artemisinin-based combination therapies (ACTs) are the first-line treatments. In severe cases, intravenous artesunate is recommended. In pregnancy, treatment is modified according to safety profiles: for instance, ACTs may be used in the second and third trimesters, while quinine plus clindamycin is preferred in the first trimester. Similar considerations apply during lactation, where many antimalarials are considered safe. Option B (Blood smear) is correct as it is the gold standard diagnostic test for malaria. CSF PCR (Option C) and Brain MRI (Option D) do not provide a diagnosis for malaria, and Option A is not provided. 1. Always consider a travel history in patients with fever and multi-system signs. 2. A peripheral blood smear remains the most accessible and definitive test for diagnosing malaria. Current WHO guidelines continue to endorse blood smears as the diagnostic gold standard for malaria, with molecular methods reserved for cases with inconclusive microscopy. Recent studies focus on rapid diagnostic tests, but their role is adjunctive rather than replacing microscopy.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "20-year-old male was found to have HIV his father asked you not to disclose the diagnosis to the son as he is planning to get married. In regards to his future wife which of the ethics principles will be broken if the diagnosis was not disclosed?",
    "option_a": "Justice",
    "option_b": "None Maleficence",
    "option_c": "Autonomy",
    "option_d": "Beneficence",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Neuro-infectious",
    "explanation": "Medical ethics involves several key principles including autonomy, beneficence, nonmaleficence, and justice. Autonomy emphasizes the right of an individual to make informed decisions about their own health and life. While not a biological process, the ethical 'pathophysiology' here refers to the breach of respect for individual decision-making. Withholding critical information, such as an HIV diagnosis, from a third party who may be at risk (in this case, the future wife) impairs her ability to make an informed decision about her own health. The scenario involves a young man diagnosed with HIV, where nondisclosure to his future wife might expose her to unrecognized health risks. Ethically, she is deprived of the information necessary to consent to a relationship where informed decisions about prevention and testing can be made. This is not a clinical diagnosis but an ethical dilemma. The evaluation involves weighing the ethical principles of patient confidentiality against the risk of harm to third parties. In many guidelines, such as the AMA\u2019s Code of Medical Ethics, the duty to warn at-risk individuals can supersede patient confidentiality in specific circumstances. Management of such ethical dilemmas involves careful counseling of the patient about the implications of nondisclosure, emphasizing the importance of protecting partners and the duty to inform. In some jurisdictions, legal and ethical frameworks may allow or even require disclosure if the partner is at significant risk. In cases involving pregnancy or potential future pregnancy, the stakes are even higher since the partner could pass the infection to offspring, necessitating prompt and transparent communication. Option A (Justice) is concerned with fairness and equality and is not the primary principle at risk in this scenario. Option B (Nonmaleficence) refers to doing no harm but is secondary here since the failure to disclose most directly impairs the partner\u2019s ability to make autonomous decisions. Option D (Beneficence) involves promoting well-being, which is also important but again is not as directly related to the issue of informed consent as autonomy. Therefore, the correct answer is Option C (Autonomy). 1. In cases of communicable diseases like HIV, the partner's right to know is paramount due to the potential for serious health consequences. 2. The duty to inform can legally and ethically override patient confidentiality when a third party is at risk. Recent discussions in bioethics emphasize that informed consent and autonomy are critical in the context of HIV. Updates in ethical guidelines and legal precedents in many regions support the notion that failing to inform sexual partners of HIV status undermines their autonomy and right to self-determination.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "What is most common area affected in TB vasculopathy?",
    "option_a": "Basal ganglia",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "Tuberculous (TB) vasculopathy is a complication of TB meningitis where inflammatory exudates lead to vasculitis and subsequent infarction. The most commonly affected region is where the perforating arteries are most vulnerable. In TB meningitis, thick exudates accumulate primarily in the basal cisterns. This exudative inflammatory process involves the perforating vessels, particularly the lenticulostriate arteries that supply the basal ganglia. Their occlusion can lead to ischemic infarcts in the basal ganglia regions. Infarcts in the basal ganglia can result in focal neurological deficits such as motor weakness and alterations in consciousness, which are commonly observed in patients with TB meningitis complicated by vasculopathy. Diagnosis involves neuroimaging (MRI or CT), which often reveals infarcts in the basal ganglia. CSF analysis supportive of TB (low glucose, high protein, lymphocytic pleocytosis, and positive acid-fast bacilli or PCR for TB) confirms the diagnosis. Differential diagnoses include non-tuberculous bacterial meningitis, vasculitis from other causes (e.g., autoimmune), and atherosclerotic stroke; however, the clinical context and CSF findings help differentiate these conditions. Management primarily involves anti-tubercular therapy (ATT), which includes drugs such as isoniazid, rifampicin, pyrazinamide, and ethambutol. Adjunctive corticosteroids are often used to reduce inflammatory exudates in TB meningitis. In patients such as pregnant or lactating women, ATT is modified according to safety profiles: for instance, isoniazid and rifampicin are generally considered safe, while streptomycin is contraindicated in pregnancy. Close monitoring for drug toxicity and interactions is essential. Option A (Basal ganglia) is correct because tuberculous vasculopathy often leads to infarcts in the small perforating vessels supplying the basal ganglia. The other options, though not explicitly stated here, would not be as common an anatomical site affected by TB vasculopathy. 1. TB meningitis most commonly affects the basal cisterns and related perforators, leading to infarction in the basal ganglia. 2. Early diagnosis and treatment with ATT and corticosteroids are critical to prevent severe neurological deficits. Recent research reinforces that the pattern of infarcts in TB meningitis typically involves the basal ganglia due to the predilection of inflammatory exudates for the basal cisterns. Updated guidelines by the World Health Organization continue to support early and aggressive treatment to minimize complications.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "HIV patient has multiple brain MRI lesions, what is the diagnosis?",
    "option_a": "CNS toxoplasmosis",
    "option_b": "PCNSL",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "In HIV-positive patients with significant immunosuppression, the development of multiple ring-enhancing lesions on brain imaging is most commonly due to reactivation of latent Toxoplasma gondii infection (CNS toxoplasmosis). This opportunistic infection is considered the primary cause of focal brain lesions in patients with low CD4 counts. In individuals with HIV/AIDS, especially those with CD4 counts less than 100 cells/mm\u00b3, the immune system's inability to control latent Toxoplasma gondii leads to reactivation. The parasites form abscesses in the brain which usually appear as multiple ring-enhancing lesions on MRI. The inflammation and necrosis in the brain tissue contribute to the clinical signs and imaging findings. Patients typically present with headaches, focal neurological deficits, confusion, and sometimes seizures. The multifocal lesions correlate with various neurological deficits depending on the location of the abscesses. The clinical picture in an HIV patient with low CD4 count, accompanied by such imaging findings, strongly points toward CNS toxoplasmosis. Initial evaluation includes brain MRI with contrast to assess lesion number and morphology. Serologic tests for Toxoplasma IgG antibodies, although not definitive for active infection, support the diagnosis in the appropriate context. In equivocal cases or poor response to therapy, brain biopsy may be considered. Differential diagnoses include primary CNS lymphoma (often seen as a solitary lesion or periventricular solitary lesion) and other opportunistic infections. First-line treatment is a combination therapy with pyrimethamine plus sulfadiazine and leucovorin (folinic acid) to prevent hematological toxicity. In patients who are pregnant, pyrimethamine is contraindicated especially in the first trimester due to teratogenicity, and alternatives (such as spiramycin) may be considered. Second-line therapies are considered if there is no clinical or radiologic improvement after a few weeks of treatment, with options including clindamycin-based regimens. Adjunctive corticosteroids may be used in cases with mass effect. Option A: CNS toxoplasmosis is correct given the clinical context of an HIV patient with multiple ring-enhancing lesions. Option B: Primary Central Nervous System Lymphoma (PCNSL) typically presents as a solitary or sometimes few lesions, often periventricular, and has a different treatment approach. The absence of other options further supports that A is the most likely answer. 1. In HIV patients with CD4 counts <100 cells/mm\u00b3, multiple brain lesions almost always indicate toxoplasmosis. 2. A positive Toxoplasma IgG in the appropriate clinical context supports the diagnosis even though it does not differentiate between past and reactivated infection. 3. Empiric treatment is often initiated based on imaging findings before invasive testing. Current guidelines from the Infectious Diseases Society of America (IDSA) and other expert bodies continue to support the use of pyrimethamine-sulfadiazine as first-line therapy for CNS toxoplasmosis in HIV patients. Recent research emphasizes early detection and treatment, as well as the importance of improving immune status with antiretroviral therapy (ART) to prevent reactivation.",
    "exam_year": "2018",
    "exam_type": "Part I",
    "image_url": "page_28.png"
  },
  {
    "question": "Patient came from Africa with fever and neurological symptoms, what to do?",
    "option_a": "Blood smear (thick and thin)",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "For patients coming from malaria-endemic regions such as Africa who present with fever and neurological symptoms, the possibility of cerebral malaria must be considered. The use of a blood smear (both thick and thin) is the standard initial diagnostic test to detect Plasmodium parasites. In cerebral malaria, primarily caused by Plasmodium falciparum, parasitized red blood cells adhere to cerebral microvasculature causing localized hypoxia and an inflammatory response. This leads to neurological manifestations in severe cases. The thick smear enhances sensitivity for detecting low levels of parasites, and the thin smear allows for species identification and parasitemia estimation. The typical clinical scenario involves fever, altered mental status, seizures, and other neurological symptoms in a patient with recent travel from or residency in a malaria-endemic area. The patient\u2019s symptoms alongside travel history make malaria a high priority in the differential diagnosis. The first diagnostic step involves obtaining blood samples for thick and thin blood smears, which can confirm the presence and type of Plasmodium species. Other differentials include bacterial meningitis, viral encephalitis, and other tropical infections such as African trypanosomiasis. Additional laboratory tests and neuroimaging might be needed depending on the presentation. The management of cerebral malaria includes immediate initiation of antimalarial therapy. Intravenous artesunate is the first-line treatment per World Health Organization (WHO) guidelines. In pregnancy, especially in the first trimester, considerations might include the use of quinine with clindamycin if artesunate is unavailable or contraindicated, given the potential risks, although current evidence supports the use of artesunate in severe malaria in all trimesters. Supportive care in an intensive care setting is often necessary. Adjunctive treatments focus on managing complications such as cerebral edema and seizures. Option A: Blood smear (thick and thin) is the appropriate initial diagnostic step. The other options are not provided and therefore cannot be evaluated; however, in this clinical scenario, the blood smear is the gold standard test for diagnosing malaria. 1. In malaria-endemic regions, fever combined with neurological signs strongly suggests cerebral malaria. 2. A thick blood smear is more sensitive for detecting parasitemia, while a thin smear helps in identifying the species. 3. Prompt diagnosis and treatment are crucial to reduce mortality in cerebral malaria. WHO and recent clinical guidelines continue to endorse the use of IV artesunate as first-line therapy for severe malaria, including cerebral malaria. Research into malaria rapid diagnostic tests (RDTs) has also expanded, but blood smears remain the diagnostic gold standard in resource-adequate settings.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "Flaccid weakness.",
    "option_a": "West Nile virus.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "West Nile virus (WNV) is known to cause neuroinvasive disease, which in some cases manifests as a poliomyelitis-like syndrome featuring acute flaccid paralysis. The virus targets motor neurons leading to rapid onset weakness. After transmission primarily through mosquito bites, WNV can cross the blood\u2013brain barrier and infect neurons, especially in the anterior horn of the spinal cord. This results in a disruption of motor neuron function leading to flaccid paralysis without sensory deficits. Clinically, affected patients may present with sudden-onset asymmetric weakness, which is typically flaccid in nature. The absence of sensory loss, combined with associated febrile illness or signs of encephalitis, supports a diagnosis of West Nile virus neuro-invasive disease. Diagnosis is based on clinical presentation and confirmed by serological testing (detection of IgM antibodies in serum and cerebrospinal fluid). Differential diagnoses include Guillain\u2013Barr\u00e9 syndrome (which typically presents with ascending weakness and areflexia), acute myelitis, and poliomyelitis. Electrophysiological studies can help differentiate these conditions. There is no specific antiviral treatment for West Nile virus; management is largely supportive and includes respiratory support if needed, pain management, and physical therapy. In pregnant or lactating women, supportive care remains the treatment of choice as the virus is managed symptomatically. Intensive supportive care in an ICU may be required for severe cases. Option A: West Nile virus is correct as it is a well-known cause of acute flaccid paralysis presenting with flaccid weakness. Other potential conditions causing flaccid paralysis (such as Guillain\u2013Barr\u00e9 syndrome or poliomyelitis) have different clinical patterns (e.g., ascending paralysis in GBS) and epidemiologic contexts. 1. West Nile virus can cause a poliomyelitis-like syndrome resulting in acute flaccid paralysis. 2. The diagnosis is often confirmed with WNV IgM in serum or CSF. 3. Supportive care is the mainstay of management as no definitive antiviral treatment exists. Recent epidemiological data underscore the sporadic nature of West Nile outbreaks with focal neurological complications. Current guidelines emphasize early recognition and supportive management. Research continues into potential targeted therapies, but none have yet altered the standard of care.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "Another scenario of CJD with EEG provided (ask about the EEG findings)",
    "option_a": "Periodic sharp waves discharges",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "Creutzfeldt\u2013Jakob disease (CJD) is a rapidly progressive neurodegenerative prion disease. EEG is one of the supportive diagnostic tools and is classically associated with periodic sharp wave complexes. CJD is caused by the misfolding of normal prion proteins into a pathogenic form that accumulates in the brain. This leads to rapidly progressive neuronal loss, spongiform changes, and a characteristic pattern of electrical activity on EEG, marked by periodic sharp wave discharges. Patients with CJD typically present with rapidly progressive dementia, myoclonus, ataxia, and visual disturbances. EEG findings of periodic sharp waves strongly support the diagnosis in the appropriate clinical context, although they are not pathognomonic. The diagnosis of CJD involves a combination of clinical evaluation, EEG, magnetic resonance imaging (MRI) showing cortical ribboning or basal ganglia hyperintensities, and CSF markers such as 14-3-3 protein. Differential diagnoses include other rapidly progressive dementias such as autoimmune encephalitis and metabolic encephalopathies. Definitive diagnosis is obtained by neuropathological examination, though it is rarely performed ante-mortem. There is no curative treatment for CJD; the management is entirely supportive, focusing on symptomatic relief and palliative care. In any patient, including pregnant and lactating women, treatment is symptomatic as no disease-modifying therapy is available. Multidisciplinary care involving neurology, palliative care, and support services is advised. Option A: Periodic sharp wave discharges is the classic EEG finding in CJD. The other options (not provided in this instance) would not align with the typical EEG pattern observed in CJD. This makes Option A the best and correct answer. 1. EEG in CJD often demonstrates periodic, biphasic or triphasic sharp wave complexes. 2. Rapidly progressive dementia with myoclonus should always raise suspicion for prion diseases. 3. CSF 14-3-3 protein and diffusion-weighted MRI are supportive, though not definitive, for the diagnosis. Recent studies have explored the utility of RT-QuIC (real-time quaking-induced conversion) assays for prion detection in CSF, which have high sensitivity and specificity. However, EEG remains a readily available, non-invasive test that, when combined with clinical and imaging findings, continues to play an important role in the diagnostic work-up of CJD.",
    "exam_year": "2018",
    "exam_type": "Part I",
    "image_url": "page_29.png"
  }
]